Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

Nippon India Pharma Fund - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic
  • NAV
    : ₹ 511.8011 -0.29%
    (as on 23rd December, 2025)
Crisil Rating

Not Rated

Rank not available for the fund
Risk-O-Meter
Very High Risk

The fund has 99.47% investment in domestic equities of which 36.84% is in Large Cap stocks, 19.05% is in Mid Cap stocks, 11.02% in Small Cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    BSE Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 22nd December, 2025)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 15-Dec-25 10044.90 0.45% - 0.45% 125/248
1 Month 21-Nov-25 9960.70 -0.39% - 0.16% 146/242
3 Month 22-Sep-25 9917.90 -0.82% - 0.60% 147/237
6 Month 20-Jun-25 10132.60 1.33% - 4.28% 182/227
YTD 01-Jan-25 9696.40 -3.04% - 4.08% 169/213
1 Year 20-Dec-24 10006.60 0.07% 0.07% 4.50% 146/210
2 Year 22-Dec-23 13386.60 33.87% 15.68% 13.86% 52/159
3 Year 22-Dec-22 17804.70 78.05% 21.18% 18.93% 40/131
5 Year 22-Dec-20 20892.30 108.92% 15.87% 19.03% 75/108
10 Year 22-Dec-15 34833.10 248.33% 13.28% 14.47% 54/76
Since Inception 05-Jun-04 513298.80 5032.99% 20.04% 11.82% 25/224

SIP Returns (NAV as on 22nd December, 2025)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 20-Dec-24 12000 12228.27 1.9 % 3.54 %
2 Year 22-Dec-23 24000 25880.42 7.84 % 7.43 %
3 Year 22-Dec-22 36000 46007.54 27.8 % 16.57 %
5 Year 22-Dec-20 60000 90200.05 50.33 % 16.3 %
10 Year 22-Dec-15 120000 300221.9 150.18 % 17.45 %
 

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 30th Nov,2025)

Portfolio Turnover Ratio : 17.00%  |   Category average turnover ratio is 167.64%  
Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)
Equity Holding : 99.47% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 99.47%
No of Stocks : 36 (Category Avg - 44.43) | Large Cap Investments : 36.84%| Mid Cap Investments : 19.05% | Small Cap Investments : 11.02% | Other : 32.56%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 11459.1 13.55% 0.88% 14.01% (Jan 2025) 11.94% (Aug 2025) 62.56 L 0.00
Lupin Ltd. Pharmaceuticals 6421.5 7.59% 0.33% 8.47% (Dec 2024) 5.82% (May 2025) 30.84 L 0.00
Divis Laboratories Ltd. Pharmaceuticals 5834.2 6.90% -1.17% 9.57% (Apr 2025) 6.9% (Nov 2025) 9.01 L -0.99 L
Cipla Ltd. Pharmaceuticals 5352 6.33% 0.04% 6.48% (Sep 2025) 5.32% (Dec 2024) 34.95 L 0.00
Dr. Reddys Laboratories Ltd. Pharmaceuticals 4929.6 5.83% 0.21% 5.91% (Sep 2025) 5.18% (Jun 2025) 39.16 L 0.00
Apollo Hospitals Enterprises Ltd. Hospital 4759.2 5.63% -0.34% 5.97% (Oct 2025) 5.14% (Feb 2025) 6.49 L 0.00
Medplus Health Services Ltd. Pharmacy retail 2933.7 3.47% 0.15% 4.2% (May 2025) 3.16% (Jan 2025) 36.27 L 0.00
Vijaya Diagnostic Centre Ltd. Healthcare service provider 2881.1 3.41% -0.01% 3.61% (Jan 2025) 3.24% (May 2025) 28.87 L 0.00
Ajanta Pharma Limited Pharmaceuticals 2456.6 2.90% 0.07% 3.17% (Jan 2025) 2.83% (Oct 2025) 9.59 L 0.00
GlaxoSmithKline Pharmaceuticals Ltd. Pharmaceuticals 2346.5 2.77% -0.10% 3.73% (May 2025) 2.02% (Jan 2025) 9.13 L 0.00
- indicates change in weight in the portfolio. # indicates a new entry.
Name Type of Instrument Weight (%)
TREPS TREPS 0.71%
Margin Margin 0.00%
Net Receivables Net Receivables -0.18%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 28th November, 2025)

  • Standard Deviation

    Low volatility
    11.41vs12.5
    Category Avg
  • Beta

    Low volatility
    0.59vs0.86
    Category Avg
  • Sharpe Ratio

    Better risk adjusted returns
    1.26vs0.98
    Category Avg
  • Treynor's Ratio

    Better risk adjusted returns
    0.25vs0.16
    Category Avg
  • Jensen's Alpha

    Better risk adjusted returns
    9.81vs3.49
    Category Avg

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Taiwan Equity Fund - Regular Plan - Growth NA 423.45 7.69 5.00 41.49 45.74 37.08
Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth NA 273.54 5.07 3.37 16.38 34.68 16.41
Quant BFSI Fund - Regular Plan - Growth NA 728.97 1.14 6.53 13.37 23.46 0.00
Nippon India Japan Equity Fund - Growth NA 289.88 4.41 2.54 15.54 22.52 15.87
Franklin Asian Equity Fund - Growth NA 297.29 3.55 3.99 16.93 22.23 12.00
HDFC Transportation and Logistics Fund - Regular Plan - Growth NA 1747.87 -0.01 -2.07 18.51 21.72 0.00
SBI Automotive Opportunities Fund - Regular Plan - Growth NA 5379.86 2.46 3.39 18.56 21.12 0.00
UTI Transportation and Logistics Fund - Growth NA 4067.49 0.12 -1.15 14.87 20.50 26.98
DSP Banking & Financial Services Fund - Regular Plan - Growth NA 1582.52 1.56 5.19 6.24 20.33 0.00
Bandhan Transportation and Logistics Fund - Regular Plan - Growth NA 678.50 1.83 1.08 17.57 20.28 26.71

More Funds from Nippon India Mutual Fund

Out of 129 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 10 is/are ranked 4 * , 15 is/are ranked 3 * , 6 is/are ranked 2 * , 3 is/are ranked 1 * , and 94 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Small Cap Fund - Growth 4 68571.85 -1.06 -2.96 -0.07 -4.97 21.90
Nippon India ETF Nifty 50 BeES 4 55666.38 0.40 3.99 4.91 12.22 14.27
Nippon India ETF Nifty 50 BeES 4 55666.38 0.40 3.99 4.91 12.22 14.27
Nippon India Large Cap Fund - Growth 5 50312.32 0.38 1.26 4.47 8.92 19.63
Nippon India Multicap Fund - Growth 4 50048.30 -0.46 -1.33 1.91 4.15 22.24
Nippon India Growth Mid Cap Fund - Growth 4 42041.60 -0.01 0.49 3.35 4.54 25.08
Nippon India ETF Gold BeES NA 34949.92 8.79 19.18 34.79 74.19 32.55
Nippon India ETF Gold BeES NA 34949.92 0.00 0.00 0.00 0.00 0.00
Nippon India Liquid Fund - Growth 2 32354.91 0.45 1.42 2.85 6.51 6.92
Nippon India Liquid Fund - Growth 2 32354.91 0.45 1.42 2.85 6.51 6.92
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347